Navigation Links
Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnson's Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
Date:9/30/2010

tant prostate cancer (NMCRPC), Amgen's Prolia has considerable commercial potential assuming it can gain approval as an anti-neoplastic agent (and improve bone metastases-free survival). Significant commercial potential in the NMCRPC setting arises from the large drug-treatable pool and potentially long treatment durations.

The report also finds that abiraterone use in the asymptomatic setting is the only emerging therapy in NMCRPC or first-line MCRPC which is likely to secure a favorable NICE appraisal, according to the majority of surveyed oncologists in the United Kingdom. Interviewed payers indicate that the premium prices of emerging therapies, (notably Revlimid and Provenge) may limit uptake although generic docetaxel will help stimulate use of emerging therapies used in combination with docetaxel because of an overall reduced cost of the regimen.

The report is based on a survey of 251 oncologists from Germany (50), France (50), Italy (51), Spain (50) and the United Kingdom (50) and interviews with 15 European payers from Germany (3), France (3), Italy (3), Spain (3) and the United Kingdom (3).

About Decision ResourcesDecision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or regis
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer
2. Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line
3. Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections
4. Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roches Actemra for Rheumatoid Arthritis
5. Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer
6. Majority of Surveyed Pharmacy Directors Expect To Cover Pfizers Tanezumab If It Is Approved for the Treatment of Chronic Pain
7. An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists
8. In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Nearly Half Will Use CDA1/CDB1
9. For Treatment of Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia, 41 Percent of Surveyed European Hematologist-Oncologists Say MabTheras Favorable Efficacy Profile is the Most Significant Driver of Their Use of This Agent
10. For Multiple Myeloma Treatment, More Surveyed European Clinicians Consider the Combination of Immunomodulatory Agents and Proteasome Inhibitors Promising With Respect to Efficacy Than Any Other Drug Regimen Combinations
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... DALLAS , July 23, 2014 ... LLC ("Plaintiff") filed suit in the 116 ... Dallas, Texas , against RegenLab USA, ... Current and Prospective Business Relationships through false ... interference; and, Business Disparagement through libel, ...
(Date:7/23/2014)... Use of Risk Evaluation and Mitigation Strategies (REMS) and ... results in $5.4 billion in lost savings annually, according ... economic consulting firm Matrix Global Advisors (MGA). ... Required by the Food and Drug Administration (FDA) for ... to improve drug safety by ensuring that the benefits ...
(Date:7/23/2014)... 23, 2014 PositiveID Corp. (OTCQB: PSID), based ... is an emerging player in the bio-threat detection ... detection and rapid medical testing. The Company,s proprietary ... Autonomous Networked Detector), was developed under contract with ... & Technology directorate, and $30 million of contract ...
Breaking Medicine Technology:New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2
... The U.S. Food and Drug Administration today ... metastatic breast cancer who have received at least ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: ... the second leading cause of cancer related death ...
... Millennium Research Group (MRG), the global authority ... latest peripheral vascular research data for multiple geographies, ... Latin America. MRG,s peripheral vascular reports ... artery disease, including stenting, percutaneous transluminal balloon angioplasty, ...
Cached Medicine Technology:FDA Approves New Treatment Option for Late-Stage Breast Cancer 2New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group 2
(Date:7/23/2014)... TX (PRWEB) July 23, 2014 Ticket ... vs. AS Roma tickets in Dallas, TX at the ... eight team tournament held in the United States and Canada ... the world including teams from La Liga, Serie A, English ... year are Manchester United, Manchester City, Olympiacos, Inter Milan, Liverpool, ...
(Date:7/23/2014)... 23, 2014 Recently, Agebc.com has launched ... the company is announcing a promotion of wedding dresses. ... will end at the end of this month. , ... popular styles, like A-line, mermaid, ball-gown, empire, and more. ... and other special-occasion dresses for women, and the company ...
(Date:7/23/2014)... Battle Creek, MI (PRWEB) July 23, 2014 ... treatment program that gets clients off to a great ... they can believe in, has launched a new Internet ... , “Many people are surprised to learn that Internet ... sexual addiction or drug addiction, but that it’s trapping ...
(Date:7/23/2014)... Pallarito HealthDay Reporter TUESDAY, ... for Obamacare, two federal appeals courts arrived at completely different ... millions of Americans who bought health insurance through the federal ... is headed for a showdown before the U.S. Supreme Court. ... Court for the District of Columbia Circuit said that the ...
(Date:7/23/2014)... arriving at the emergency department, the drug ketamine ... rapid, life-saving intubation, despite decades-old studies that suggested ... a systematic review of 10 recent studies of ... drug" are published online in Annals of ... on Intracranial and Cerebral Perfusion Pressure and Health ...
Breaking Medicine News(10 mins):Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 3Health News:Ketamine can be a wonder drug for ER patients and their physicians 2
... (HealthDay News) -- A gene variant associated with asthma ... of researchers working together in a new national collaboration ... was not present in European Americans and may be ... in black Americans. The researchers, analysis of data ...
... August issue of the Journal of the American College ... in head computed tomography (CT) scans. Head CT is the ... the total number of CT examinations. Magnetic resonance imaging ... a vast majority of brain and spinal indications. However, CT ...
... (HealthDay News) -- Several biomechanical differences appear to separate ... could the study identify ways for recreational golfers to ... said the Stanford University School of Medicine team that ... cameras to analyze the full golf swings -- from ...
... Laxenburg, Austria 28 July 2011 -- Future trends ... improvements in both the quality and quantity of education, ... do not explicitly include education in their analysis may ... journal Science (July 29 2011). ...
... FRIDAY, July 29 (HealthDay News) -- A growing number of ... in which they spend three or more nights together each ... own homes, a new study shows. "Instead of following ... to engage in romantic ties on their own terms ...
... will begin a Phase 1 clinical trial on a ... represents the first new class of anti-TB drugs in ... both drug-susceptible and drug-resistant TB. The study is ... awarded from the National Institutes of Health through the ...
Cached Medicine News:Health News:Education -- a key determinant of population growth and human well-being 2Health News:Education -- a key determinant of population growth and human well-being 3Health News:Even Living Together Is Too Much Commitment for Today's Couples 2
... The Cadwell Cascade is a powerful, multi-modality system ... free-run EMG, stimulated EMG, EEG, and train of ... with portability as a priority. The base weighs ... weighs just 13 lbs. A desktop PC-based system ...
... Endeavor is a neuromonitoring system especially ... monitoring. Endeavor amplifier has 16 channels and ... active electrode inputs. Each channel can be ... or a true differential channel. Endeavor amplifiers ...
... Katena Products, Inc. is the ... dedicated exclusively to ophthalmic surgical ... to over 7,000 customers in ... a global network of distributors, ...
... Blood glucose, medication, food, exercise, stress . ... a diabetes patients overall health. Unfortunately, its ... this vital information on a daily basis. ... day-to-day results or submit the information to ...
Medicine Products: